Literature DB >> 25081711

Analysis of cancer incidence in Zhejiang cancer registry in China during 2000 to 2009.

Ling-Bin Du1, Hui-Zhang Li, Xiang-Hui Wang, Chen Zhu, Qing-Min Liu, Qi-Long Li, Xue-Qin Li, Yong-Zhou Shen, Xin-Pei Zhang, Jiang-Wei Ying, Chuan-Ding Yu, Wei-Min Mao.   

Abstract

OBJECTIVE: The Zhejiang Provincial Cancer Prevention and Control Office collected cancer registration data during 2000 to 2009 from 6 cancer registries in Zhejiang province of China in order to analyze the cancer incidence.
METHODS: Descriptive analysis included cancer incidence stratified by sex, age and cancer site group. The proportions and cumulative rates of 10 common cancers in different groups were also calculated. Chinese population census in 1982 and Segi's population were used for calculating age-standardized incidence rates. The log-linear model was used for fitting to calculate the incidence trends.
RESULTS: The 6 cancer registries in Zhejiang province in China covered a total of 60,087,888 person-years during 2000 to 2009 (males 30,445,904, females 29,641,984). The total number of new cancer cases were 163,104 (males 92,982, females 70,122). The morphology verified cases accounted for 69.7%, and the new cases verified only by information from death certification accounted for 1.23%. The crude incidence rate in Zhejiang cancer registration areas was 271.5/105 during 2000 to 2009 (male 305.41/105, female 236.58/105), age-standardized incidence rates by Chinese standard population (ASIRC) and by world standard population (ASIRW) were 147.1/105 and 188.2/105, the cumulative incidence rate (aged from 0 to 74) being 21.7%. The crude incidence rate was 209.6/105 in 2000, and it increased to 320.20/105 in 2009 (52.8%), with an annual percent change (APC) of 4.51% (95% confidence interval, 3.25%-5.79%). Age-specific incidence rate of 80-84 age group was achieved at the highest point of the incidence curve. Overall with different age groups, the cancer incidences differed, the incidence of liver cancer being highest in 15-44 age group in males; the incidence of breast cancer was the highest in 15-64 age group in females; the incidences of lung cancer were the highest in both males and females over the age of 65 years.
CONCLUSIONS: Lung cancer, digestive system malignancies and breast cancer are the most common cancers in Zhejiang province in China requiring an especial focus. The incidences of thyroid cancer, prostate cancer, cervical cancer and lymphoma have increased rapidly. Prevention and control measures should be implemented for these cancers.

Entities:  

Mesh:

Year:  2014        PMID: 25081711     DOI: 10.7314/apjcp.2014.15.14.5839

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  9 in total

1.  KCNQ1OT1/miR-217/ZEB1 feedback loop facilitates cell migration and epithelial-mesenchymal transition in colorectal cancer.

Authors:  Yinzhu Bian; Guangyi Gao; Qun Zhang; Hanqing Qian; Lixia Yu; Ninghua Yao; Jing Qian; Baorui Liu; Xiaoping Qian
Journal:  Cancer Biol Ther       Date:  2019-02-22       Impact factor: 4.742

2.  miR-31-5p Regulates 14-3-3 ɛ to Inhibit Prostate Cancer 22RV1 Cell Survival and Proliferation via PI3K/AKT/Bcl-2 Signaling Pathway.

Authors:  Jiafu Zhao; Houqiang Xu; Zhiqiang Duan; Xiang Chen; Zheng Ao; Yinglian Chen; Yong Ruan; Mengmeng Ni
Journal:  Cancer Manag Res       Date:  2020-07-31       Impact factor: 3.989

3.  Time trends and age-period-cohort analyses on incidence rates of thyroid cancer in Shanghai and Hong Kong.

Authors:  Shao-Hua Xie; Juan Chen; Bo Zhang; Feng Wang; Shan-Shan Li; Chang-Hui Xie; Lap-Ah Tse; Jin-Quan Cheng
Journal:  BMC Cancer       Date:  2014-12-18       Impact factor: 4.430

4.  Combination of phospholipase Cε knockdown with GANT61 sensitizes castration‑resistant prostate cancer cells to enzalutamide by suppressing the androgen receptor signaling pathway.

Authors:  Wei Sun; Luo Li; Zhongbo Du; Zhen Quan; Mengjuan Yuan; Honglin Cheng; Yingying Gao; Chunli Luo; Xiaohou Wu
Journal:  Oncol Rep       Date:  2019-03-07       Impact factor: 4.136

5.  Concurrent Learning Curves of 3-Dimensional and Robotic-Assisted Laparoscopic Radical Hysterectomy for Early-Stage Cervical Cancer Using 2-Dimensional Laparoscopic Radical Hysterectomy as a Benchmark: A Single Surgeon's Experience.

Authors:  Ding Ding; Hongyuan Jiang; Jichan Nie; Xishi Liu; Sun-Wei Guo
Journal:  Med Sci Monit       Date:  2019-08-08

6.  Expression of HIF-1α and HIF-2α correlates to biological and clinical significance in papillary thyroid carcinoma.

Authors:  Yan-Mei Liu; Shen-Peng Ying; Ying-Rui Huang; Yin Pan; Wei-Jun Chen; Ling-Qin Ni; Jin-Ye Xu; Qin-Yan Shen; Yong Liang
Journal:  World J Surg Oncol       Date:  2016-02-04       Impact factor: 2.754

7.  Low LKB1 Expression Results in Unfavorable Prognosis in Prostate Cancer Patients.

Authors:  Jianlei Lu; Peng Sun; Beibei Sun; Chao Wang
Journal:  Med Sci Monit       Date:  2015-11-30

8.  Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China.

Authors:  Lingbin Du; Youqing Wang; Xiaohui Sun; Huizhang Li; Xinwei Geng; Minghua Ge; Yimin Zhu
Journal:  BMC Cancer       Date:  2018-03-15       Impact factor: 4.430

9.  Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCε/PKCε Signaling Pathway.

Authors:  Jiayu Liu; Yongbo Zheng; Yingying Gao; Zhen Quan; Bo Qiao; Luo Li; Ting Li; Limei Duan; Jinxiao Yang; Chunli Luo; Xiaohou Wu
Journal:  Front Oncol       Date:  2020-02-25       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.